Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 906,800 | 496,000 | 247,100 | 245,300 | 787,000 |
| Depreciation Amortization | 199,400 | 245,100 | 254,700 | 265,500 | 280,400 |
| Income taxes - deferred | -47,500 | 54,700 | -57,600 | -66,300 | -140,200 |
| Accounts receivable | -77,100 | -18,000 | 134,500 | 124,300 | 36,100 |
| Accounts payable and accrued liabilities | -14,100 | 44,700 | 54,300 | -62,400 | -6,200 |
| Other Working Capital | -140,000 | -43,600 | 301,200 | -318,500 | 123,900 |
| Other Operating Activity | -373,000 | -8,300 | -67,900 | 629,700 | -115,700 |
| Operating Cash Flow | $454,500 | $770,600 | $866,300 | $817,600 | $965,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -9,800 | N/A |
| PPE Investments | 1,057,100 | -80,600 | -141,600 | -157,100 | -197,800 |
| Net Acquisitions | -45,600 | N/A | -121,900 | -107,300 | 942,000 |
| Sale Of Investment | 22,500 | 0 | 58,400 | N/A | N/A |
| Other Investing Activity | -115,800 | 7,600 | -8,100 | 0 | 0 |
| Investing Cash Flow | $918,200 | $-73,000 | $-213,200 | $-274,200 | $744,200 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -34,400 | 1,300 | 11,100 | -197,000 | -1,559,100 |
| Debt Issued | 500,000 | 0 | 895,800 | 790,000 | 1,000 |
| Debt Repayment | -2,440,900 | -166,500 | -1,194,300 | -205,800 | -4,700 |
| Common Stock Issued | 102,300 | 40,600 | 6,900 | 21,500 | 80,800 |
| Common Stock Repurchased | N/A | N/A | N/A | -278,600 | N/A |
| Dividend Paid | -118,600 | -121,000 | -152,200 | -261,200 | -248,600 |
| Other Financing Activity | -10,900 | -2,900 | 400 | -424,700 | 17,600 |
| Financing Cash Flow | $-2,002,500 | $-248,500 | $-432,300 | $-555,800 | $-1,713,000 |
| Exchange Rate Effect | -16,600 | -1,600 | 33,100 | -28,000 | 24,500 |
| Beginning Cash Position | 811,500 | 364,800 | 122,200 | 203,700 | 182,700 |
| End Cash Position | 218,300 | 811,500 | 364,800 | 163,300 | 203,700 |
| Net Cash Flow | $-593,200 | $446,700 | $242,600 | $-40,400 | $21,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 454,500 | 770,600 | 866,300 | 817,600 | 965,300 |
| Capital Expenditure | -218,500 | -223,000 | -157,500 | -176,300 | -267,100 |
| Free Cash Flow | 236,000 | 547,600 | 708,800 | 641,300 | 698,200 |